APA (7th ed.) Citation

K, E., JE, S., J, B., MP, M., J, K., J, T., . . . DN, H. (2022). Accelerate Clinical Trials in Charcot-Marie-Tooth Disease (ACT-CMT): A Protocol to Address Clinical Trial Readiness in CMT1A. Frontiers in neurology, 13, 930435. https://doi.org/10.3389/fneur.2022.930435

Chicago Style (17th ed.) Citation

K, Eichinger, et al. "Accelerate Clinical Trials in Charcot-Marie-Tooth Disease (ACT-CMT): A Protocol to Address Clinical Trial Readiness in CMT1A." Frontiers in Neurology 13 (2022): 930435. https://doi.org/10.3389/fneur.2022.930435.

MLA (9th ed.) Citation

K, Eichinger, et al. "Accelerate Clinical Trials in Charcot-Marie-Tooth Disease (ACT-CMT): A Protocol to Address Clinical Trial Readiness in CMT1A." Frontiers in Neurology, vol. 13, 2022, p. 930435, https://doi.org/10.3389/fneur.2022.930435.